This inventor holds 24 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 6 EPO patents, primarily in Biopharmaceutical Innovations. Top assignees: Zymogenetics, Inc., The Government of the United States of America, Whitehead Institute for Biomedical Research. Active years: 1989-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Morristown, NJ (US) (1989)
- Bensalem, PA (US) (1989)
- Seattle, WA (US) (2005 - 2020)
Company Filing History:
18 out of 723 
2 out of 12 
2 out of 318 
Years Active: 1989-2020
Areas of Expertise:
Title: Innovations by Steven D. Levin in the Field of Inflammatory Treatments
Introduction: Steven D. Levin is an influential inventor based in Seattle, Washington, renowned for his significant contributions to medical therapies targeting inflammation. With a remarkable portfolio of 24 patents, Levin's work has paved the way for innovative approaches in treating diseases associated with human cytokines.
Latest Patents: Among his latest patents, Levin has developed treatments involving IL-17/IL-23 bispecific antibodies. This invention focuses on blocking, inhibiting, and neutralizing the activities of IL-17A, IL-17F, and IL-23, which are cytokines crucial to inflammatory processes. The patent describes various antagonists, including antibodies and antibody fragments that specifically bind to IL-23, IL-17A, or IL-17F. Furthermore, the innovations include antibodies that exhibit cross-reactivity for IL-17A and IL-17F, presenting new avenues for therapeutic interventions.
Career Highlights: Levin's career features impactful employment at Zymogenetics, Inc., where he played a pivotal role in advancing biopharmaceutical research. His innovative spirit has led to breakthroughs that are now influential in the treatment protocols for inflammatory diseases.
Collaborations: Throughout his career, Levin has collaborated with esteemed colleagues, including Katherine E. Lewis and Scott R. Presnell. These partnerships have harnessed collective expertise, driving forward the mission to develop effective treatment methods that address critical health issues.
Conclusion: Steven D. Levin's contributions to the field of inflammation treatment through his inventive patents highlight the importance of innovation in medical science. His ongoing research and collaboration reflect a dedicated effort to improve patient outcomes and offer new therapeutic options for those affected by inflammatory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile